Tower Research Capital LLC (TRC) - ICU MED INC ownership

ICU MED INC's ticker is ICUI and the CUSIP is 44930G107. A total of 292 filers reported holding ICU MED INC in Q1 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ICU MED INC
ValueSharesWeighting
Q3 2023$242,304
-61.4%
2,036
-42.1%
0.01%
-61.9%
Q2 2023$627,051
+282355.4%
3,519
+161.6%
0.02%
+200.0%
Q1 2023$222
+241.5%
1,345
+227.3%
0.01%
+133.3%
Q4 2022$65
-100.0%
411
-76.3%
0.00%
-25.0%
Q3 2022$261,000
-79.8%
1,734
-77.9%
0.00%
-86.2%
Q2 2022$1,290,000
+29.4%
7,845
+75.2%
0.03%
+190.0%
Q1 2022$997,000
+113.5%
4,479
+127.4%
0.01%
+25.0%
Q4 2021$467,000
+47.8%
1,970
+45.5%
0.01%0.0%
Q3 2021$316,000
+20.2%
1,354
+5.9%
0.01%
+14.3%
Q2 2021$263,000
+26.4%
1,278
+26.0%
0.01%
+75.0%
Q1 2021$208,000
-82.1%
1,014
-81.3%
0.00%
-88.6%
Q4 2020$1,160,000
-9.3%
5,410
-22.7%
0.04%
+150.0%
Q3 2020$1,279,000
+31.6%
6,997
+32.7%
0.01%
-65.0%
Q2 2020$972,000
+2109.1%
5,273
+2296.8%
0.04%
+1233.3%
Q1 2020$44,000
-77.8%
220
-79.2%
0.00%
-81.2%
Q4 2019$198,000
+1314.3%
1,057
+1129.1%
0.02%
+1500.0%
Q3 2019$14,000
-78.5%
86
-66.7%
0.00%
-75.0%
Q2 2019$65,000
-57.2%
258
-59.2%
0.00%
-55.6%
Q1 2019$152,000
+289.7%
632
+274.0%
0.01%
+200.0%
Q4 2018$39,000
-91.3%
169
-89.3%
0.00%
-90.9%
Q3 2018$447,000
+794.0%
1,579
+828.8%
0.03%
+1000.0%
Q2 2018$50,000
-61.2%
170
-66.8%
0.00%
-72.7%
Q1 2018$129,000
-65.5%
512
-74.5%
0.01%
-64.5%
Q3 2017$374,000
+2776.9%
2,010
+2237.2%
0.03%
+3000.0%
Q1 2017$13,000
-45.8%
86
-46.6%
0.00%
-66.7%
Q4 2016$24,000
-80.6%
161
-85.4%
0.00%
-75.0%
Q2 2016$124,000
+226.3%
1,102
+168.8%
0.01%
+140.0%
Q1 2015$38,000
+3700.0%
410
+4455.6%
0.01%
Q4 2014$1,000
-99.1%
9
-99.5%
0.00%
-100.0%
Q3 2014$109,000
+890.9%
1,691
+877.5%
0.01%
+1100.0%
Q2 2014$11,000
-38.9%
173
-41.9%
0.00%
-50.0%
Q1 2014$18,000
-80.9%
298
-78.6%
0.00%
-80.0%
Q3 2013$94,000
+248.1%
1,394
+270.7%
0.01%
+400.0%
Q2 2013$27,0003760.00%
Other shareholders
ICU MED INC shareholders Q1 2022
NameSharesValueWeighting ↓
NUANCE INVESTMENTS, LLC 1,035,101$212,651,0003.97%
EVR Research LP 22,000$4,520,0003.44%
Tamarack Advisers, LP 70,000$14,381,0002.95%
Nitorum Capital, L.P. 252,668$51,908,0002.56%
PFM Health Sciences, LP 290,661$59,713,0001.82%
KIRR MARBACH & CO LLC /IN/ 22,298$4,581,0001.33%
Findlay Park Partners LLP 671,136$137,878,0000.96%
PURA VIDA INVESTMENTS, LLC 148,548$30,518,0000.87%
Redmile Group, LLC 224,154$46,050,0000.65%
Canvas Wealth Advisors, LLC 5,177$1,064,0000.62%
View complete list of ICU MED INC shareholders